197 related articles for article (PubMed ID: 25330944)
1. Hydroxyoctadecadienoic acids regulate apoptosis in human THP-1 cells in a PPARγ-dependent manner.
Vangaveti VN; Shashidhar VM; Rush C; Malabu UH; Rasalam RR; Collier F; Baune BT; Kennedy RL
Lipids; 2014 Dec; 49(12):1181-92. PubMed ID: 25330944
[TBL] [Abstract][Full Text] [Related]
2. Differential modulation of cell cycle, apoptosis and PPARgamma2 gene expression by PPARgamma agonists ciglitazone and 9-hydroxyoctadecadienoic acid in monocytic cells.
Hampel JK; Brownrigg LM; Vignarajah D; Croft KD; Dharmarajan AM; Bentel JM; Puddey IB; Yeap BB
Prostaglandins Leukot Essent Fatty Acids; 2006 May; 74(5):283-93. PubMed ID: 16647253
[TBL] [Abstract][Full Text] [Related]
3. 9- and 13-HODE regulate fatty acid binding protein-4 in human macrophages, but does not involve HODE/GPR132 axis in PPAR-γ regulation of FABP4.
Vangaveti V; Shashidhar V; Collier F; Hodge J; Rush C; Malabu U; Baune B; Kennedy RL
Ther Adv Endocrinol Metab; 2018 May; 9(5):137-150. PubMed ID: 29796244
[TBL] [Abstract][Full Text] [Related]
4. Differential cell growth/apoptosis behavior of 13-hydroxyoctadecadienoic acid enantiomers in a colorectal cancer cell line.
Cabral M; Martín-Venegas R; Moreno JJ
Am J Physiol Gastrointest Liver Physiol; 2014 Sep; 307(6):G664-71. PubMed ID: 25035111
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of PPARγ agonist activities of stereo-, regio-, and enantio-isomers of hydroxyoctadecadienoic acids.
Umeno A; Sakashita M; Sugino S; Murotomi K; Okuzawa T; Morita N; Tomii K; Tsuchiya Y; Yamasaki K; Horie M; Takahara K; Yoshida Y
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32266936
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyoctadecadienoic acids: novel regulators of macrophage differentiation and atherogenesis.
Vangaveti V; Baune BT; Kennedy RL
Ther Adv Endocrinol Metab; 2010 Apr; 1(2):51-60. PubMed ID: 23148150
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory effects of polyunsaturated fatty acids in THP-1 cells.
Zhao G; Etherton TD; Martin KR; Vanden Heuvel JP; Gillies PJ; West SG; Kris-Etherton PM
Biochem Biophys Res Commun; 2005 Oct; 336(3):909-17. PubMed ID: 16169525
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor gamma ligands isolated from adlay seed (Coix lacryma-jobi L. var. ma-yuen STAPF.).
Yokoi H; Mizukami H; Nagatsu A; Ohno T; Tanabe H; Inoue M
Biol Pharm Bull; 2009 Apr; 32(4):735-40. PubMed ID: 19336916
[TBL] [Abstract][Full Text] [Related]
9. 13-Oxo-ODE is an endogenous ligand for PPARgamma in human colonic epithelial cells.
Altmann R; Hausmann M; Spöttl T; Gruber M; Bull AW; Menzel K; Vogl D; Herfarth H; Schölmerich J; Falk W; Rogler G
Biochem Pharmacol; 2007 Aug; 74(4):612-22. PubMed ID: 17604003
[TBL] [Abstract][Full Text] [Related]
10. Troglitazone but not conjugated linoleic acid reduces gene expression and activity of matrix-metalloproteinases-2 and -9 in PMA-differentiated THP-1 macrophages.
Ringseis R; Schulz N; Saal D; Eder K
J Nutr Biochem; 2008 Sep; 19(9):594-603. PubMed ID: 18155510
[TBL] [Abstract][Full Text] [Related]
11. Stereoisomer-Specific Induction of G2/M Phase Arrest and Apoptosis by 9-(E,Z)-Hydroxyoctadecadienoic Acid in Mouse Lymphoma Cells.
Kodaka A; Hayakawa Y; AlSayegh RJ; Yasuhara T; Tomoda H; Oku T; Dan S; Tsuiji M; Tsuji T
Biol Pharm Bull; 2019; 42(6):937-943. PubMed ID: 31155590
[TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone, a PPARγ agonist, ameliorates palmitate-induced insulin resistance and apoptosis in skeletal muscle cells.
Meshkani R; Sadeghi A; Taheripak G; Zarghooni M; Gerayesh-Nejad S; Bakhtiyari S
Cell Biochem Funct; 2014 Dec; 32(8):683-91. PubMed ID: 25431031
[TBL] [Abstract][Full Text] [Related]
13. Relaxin signaling activates peroxisome proliferator-activated receptor gamma.
Singh S; Bennett RG
Mol Cell Endocrinol; 2010 Feb; 315(1-2):239-45. PubMed ID: 19712722
[TBL] [Abstract][Full Text] [Related]
14.
Foster JR; Ueno S; Chen MX; Harvey J; Dowell SJ; Irving AJ; Brown AJ
Pharmacol Res Perspect; 2019 Dec; 7(6):e00542. PubMed ID: 31768260
[TBL] [Abstract][Full Text] [Related]
15. Identification of 9-hydroxyoctadecadienoic acid and other oxidized free fatty acids as ligands of the G protein-coupled receptor G2A.
Obinata H; Hattori T; Nakane S; Tatei K; Izumi T
J Biol Chem; 2005 Dec; 280(49):40676-83. PubMed ID: 16236715
[TBL] [Abstract][Full Text] [Related]
16. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
Lin MS; Chen WC; Bai X; Wang YD
J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
[TBL] [Abstract][Full Text] [Related]
17. Macrophage PPARγ inhibits Gpr132 to mediate the anti-tumor effects of rosiglitazone.
Cheng WY; Huynh H; Chen P; Peña-Llopis S; Wan Y
Elife; 2016 Oct; 5():. PubMed ID: 27692066
[TBL] [Abstract][Full Text] [Related]
18. G2A plays proinflammatory roles in human keratinocytes under oxidative stress as a receptor for 9-hydroxyoctadecadienoic acid.
Hattori T; Obinata H; Ogawa A; Kishi M; Tatei K; Ishikawa O; Izumi T
J Invest Dermatol; 2008 May; 128(5):1123-33. PubMed ID: 18034171
[TBL] [Abstract][Full Text] [Related]
19. Activation of peroxisome proliferator-activated receptor-γ (PPARγ) inhibits hepatoma cell growth via downregulation of SEPT2 expression.
Cao LQ; Shao ZL; Liang HH; Zhang DW; Yang XW; Jiang XF; Xue P
Cancer Lett; 2015 Apr; 359(1):127-35. PubMed ID: 25592041
[TBL] [Abstract][Full Text] [Related]
20. G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY.
Wang S; Awad KS; Elinoff JM; Dougherty EJ; Ferreyra GA; Wang JY; Cai R; Sun J; Ptasinska A; Danner RL
J Biol Chem; 2015 Aug; 290(32):19544-57. PubMed ID: 26105050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
